- Home
- CBAT vs INO Comparison
CBAT vs INO Comparison
Compare CBAT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- INO
- Stock Information
- Founded
- CBAT 1999
- INO 1979
- Country
- CBAT China
- INO United States
- Employees
- CBAT N/A
- INO N/A
- Industry
- CBAT Industrial Machinery/Components
- INO Medical/Dental Instruments
- Sector
- CBAT Miscellaneous
- INO Health Care
- Exchange
- CBAT Nasdaq
- INO Nasdaq
- Market Cap
- CBAT 83.0M
- INO 75.4M
- IPO Year
- CBAT N/A
- INO 1998
- Fundamental
- Price
- CBAT $0.86
- INO $2.24
- Analyst Decision
- CBAT
- INO Buy
- Analyst Count
- CBAT 0
- INO 6
- Target Price
- CBAT N/A
- INO $17.00
- AVG Volume (30 Days)
- CBAT 197.4K
- INO 739.9K
- Earning Date
- CBAT 03-14-2025
- INO 03-05-2025
- Dividend Yield
- CBAT N/A
- INO N/A
- EPS Growth
- CBAT N/A
- INO N/A
- EPS
- CBAT 0.12
- INO N/A
- Revenue
- CBAT $207,423,403.00
- INO $203,413.00
- Revenue This Year
- CBAT $0.46
- INO N/A
- Revenue Next Year
- CBAT $13.78
- INO $1,970.14
- P/E Ratio
- CBAT $7.12
- INO N/A
- Revenue Growth
- CBAT 2.32
- INO N/A
- 52 Week Low
- CBAT $0.77
- INO $1.74
- 52 Week High
- CBAT $2.08
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- CBAT 41.36
- INO 54.46
- Support Level
- CBAT $0.85
- INO $1.82
- Resistance Level
- CBAT $0.92
- INO $2.31
- Average True Range (ATR)
- CBAT 0.04
- INO 0.14
- MACD
- CBAT -0.00
- INO 0.05
- Stochastic Oscillator
- CBAT 10.00
- INO 83.17
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.